Table 4.

Recurrence free survival (RFS) and overall survival (OS) of candidate hub genes.

Gene name		Multivariate analysis for RFS			Univariate analysis for RFS			Multivariate analysis for OS			Univariate analysis for OS
Probe ID	Symbole	HR	CI	logrank P	HR	CI	logrank P	HR	CI	logrank P	HR	CI	logrank P
210794_s_at	MEG3	0.8	0.71–0.89	0.0001	0.73	0.65–0.81	1.30e−08	0.93	0.74–1.17	0.5396	0.82	0.66–1.02	0.0713
227061_at	LINC01279	0.74	0.63–0.87	0.0003	0.69	0.59–0.81	4.2e−06	0.73	0.53–1.01	0.0553	0.72	0.53–0.99	0.0391
235124_at	EIF3J-DT	0.57	0.48–0.68	0	0.5	0.42–0.58	< 1e−16	0.76	0.54–1.07	0.1189	0.62	0.45–0.85	0.0029
226369_at	LINC01089	0.5	0.42–0.58	0	0.46	0.39–0.54	< 1e−16	0.84	0.6–1.17	0.2993	0.72	0.53–0.99	0.0433
1560081_at	RAD51-AS1	0.45	0.38–0.53	0	0.41	0.35–0.49	< 1e−16	0.7	0.5–0.99	0.0427	0.61	0.45–0.84	0.0023
232190_x_at	TNFRSF14-AS1	0.63	0.54–0.74	0	0.58	0.5–0.68	1.4e−11	0.86	0.62–1.18	0.3494	0.76	0.55–1.04	0.0868
234423_x_at	LINC02256	0.63	0.53–0.74	0	0.58	0.49–0.68	5.2e−12	1.26	0.91–1.75	0.1708	1.06	0.78–1.46	0.6976
216051_x_at	PRINS	0.7	0.63–0.78	0	0.69	0.62–0.77	2.4e−11	0.91	0.73–1.13	0.3928	0.86	0.69–1.06	0.1658
225698_at	EPB41L4A-AS1	0.77	0.65–0.91	0.0023	0.65	0.55–0.76	3.3e−08	0.91	0.65–1.28	0.5966	0.75	0.55–1.03	0.0781
1558828_s_at	CARMN	0.62	0.53–0.73	0	0.59	0.51–0.69	5.3e−11	0.61	0.44–0.84	0.0028	0.56	0.41–0.77	0.0003
242889_x_at	FUT8-AS1	0.8	0.68–0.93	0.0046	0.75	0.64–0.88	0.00028	1.74	1.25–2.43	0.0011	1.54	1.11–2.12	0.0083
228799_at	NCK1-DT	1.06	0.91–1.25	0.4498	1.18	1.01–1.38	0.035	0.95	0.68–1.32	0.751	1.09	0.8–1.49	0.5982
203418_at	CCNA2	1.24	1.09–1.42	0.0011	1.84	1.64–2.05	< 1e−16	1.36	1.05–1.77	0.0193	1.55	1.25–1.93	5.0e−05
203362_s_at	MAD2L1	1.66	1.47–1.87	0	1.86	1.67–2.08	< 1e−16	1.8	1.42–2.28	0	2.02	1.62–2.51	1.8e−10

HR, hazard ratio; CI, confidence interval; RFS, recurrence free survival; OS, overall survival.

A multivariate analysis was performed for MKI67, ESR1, and HER2 (ERBB2).